Popular Content
Generic Trends

Court Instructs FDA to Approve Watson’s Generic Actos 11/20/2012

Daily Multivitamins Reduce Risk of Cancer in Men 11/20/2012

Par to Acquire 14 Generics 11/14/2012

Amarin Announces Approval of Generic for Hypertriglyceridemia 9/19/2012

Amneal to Invest $120 Million in Three Facilities 9/19/2012

GPhA Receives Favorable Opinion on Shortage Initiative 9/19/2012

Austerity Pricing Tactics Support Generic Drug Growth in Europe 8/21/2012

Impax Laboratories Enters Into Agreement With TOLMAR, Inc. 8/21/2012

Par Pharmaceutical Companies Enters Agreement to Be Acquired by TPG 8/21/2012

Prodigy Health Supplier Partners With Stason Pharmaceuticals 8/21/2012

Draft Guidance Issued on Biosimilars 4/23/2012

FDA Strengthens Supply of Cancer Drugs 4/23/2012

Amerigen and VIWA to Develop Generics for Chinese Market 2/17/2012

Mylan Confirms Actoplus Met XR Tablets Patent Challenge 2/17/2012

Perrigo Files ANDA for Generic Astepro 2/17/2012

GPhA Lobbies for Fully Funded FDA and OGD 11/16/2011

Prasco Is Eli Lilly's Authorized Generic Partner 11/16/2011

Study: Generics Saved $931 Billion Over Past 10 Years 11/16/2011

Generic Docetaxel Approved 4/20/2011

Glenmark's Levocetirizine Dihydrochloride Approved 4/20/2011

For more articles, please check our archives.